Multimodality therapy for cancers of the esophagus and gastric cardia.
The role of multimodal treatment in the management of esophageal cancer is controversial. There are conflicting results from studies on the effect of neoadjuvant and/or adjuvant treatment on long-term survival. Following a search of the Medline database, the authors examine the results of randomized studies on the various treatment protocols available and discuss future therapeutic improvements.
Naughton
Peter
P
Department of Surgery, James Connolly Memorial Hospital, Blanchardstown, Dublin 15, Ireland. peternaughton74@eircom.net
Walsh
Thomas N
TN
D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D002299:Cardia; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000628:therapy*; D006801:Humans; D018714:Radiotherapy, Adjuvant; D013274:Stomach Neoplasms / Q000628:therapy*